BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12441262)

  • 1. Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases.
    McKay JA; Murray LJ; Curran S; Ross VG; Clark C; Murray GI; Cassidy J; McLeod HL
    Eur J Cancer; 2002 Nov; 38(17):2258-64. PubMed ID: 12441262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas.
    Saeki T; Salomon DS; Johnson GR; Gullick WJ; Mandai K; Yamagami K; Moriwaki S; Tanada M; Takashima S; Tahara E
    Jpn J Clin Oncol; 1995 Dec; 25(6):240-9. PubMed ID: 8523820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
    Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
    Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
    Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
    Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
    J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
    Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal Growth Factor Receptor Expression of Colorectal Carcinoma in Nigerian Patients.
    Lawan AI; Ogunbiyi JO
    West Afr J Med; 2020; 37(2):100-105. PubMed ID: 32150626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR expression variance in paired colorectal cancer primary and metastatic tumors.
    Yarom N; Marginean C; Moyana T; Gorn-Hondermann I; Birnboim HC; Marginean H; Auer RC; Vickers M; Asmis TR; Maroun J; Jonker D
    Cancer Biol Ther; 2010 Sep; 10(5):416-21. PubMed ID: 20595818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.
    Precht C; Blessmann M; Kluwe L; Scheld T; Schön G; Henningsen A; Pflug C; Smeets R; Heiland M; Gröbe A
    Eur J Oral Sci; 2017 Apr; 125(2):95-101. PubMed ID: 28150908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical study on the expression of epidermal growth factor receptor (EGFR) in human colorectal carcinomas].
    Takemura K; Obara T; Okano S; Yokota K; Ura H; Saitoh Y; Koike Y; Okamura K; Namiki M
    Nihon Shokakibyo Gakkai Zasshi; 1991 May; 88(5):1177-83. PubMed ID: 1880949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma.
    Sun XF; Ekberg H; Zhang H; Carstensen JM; Nordenskjöld B
    APMIS; 1998 Jun; 106(6):657-64. PubMed ID: 9725799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
    Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
    Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
    Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
    APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological features.
    Mohammadi G; Jamialahmadi K; Lary S; Ghaffarzadegan K
    Pak J Biol Sci; 2011 Mar; 14(5):357-62. PubMed ID: 21874828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
    Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
    Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
    Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
    Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.